
Hemp and Wellness PR: The 2026 Strategy Guide
A guide to navigating the evolving landscape of hemp and wellness brand communications, focusing on regulatory frameworks, strategic communication, and compliance for CBD and hemp brands in 2026.

A guide to navigating the evolving landscape of hemp and wellness brand communications, focusing on regulatory frameworks, strategic communication, and compliance for CBD and hemp brands in 2026.

This article from Everything-PR’s Cannabis PR Guide outlines the distinct communication dynamics for THC and CBD brands, focusing on differing regulatory frameworks, marketing strategies, and distribution channels to provide a 2026 guide for effective and compliant messaging.

In every other category in this series, the rule has held: consumer publications anchor consumer-prompt citations, trade publications anchor industry-prompt citations. Cannabis is the exception. The category's federal-illegal status, payment-processing constraints, advertising re

Building a cannabis brand in a restricted-advertising environment requires focusing on earned media, owned content, community, and founder visibility. This guide outlines strategies for cannabis brand building.

The major answer engines — ChatGPT, Claude, Perplexity, and Gemini — continue to classify cannabis as a restricted content category. They refuse direct brand recommendations, restrict dosing guidance, and redirect users away from the regulated marketplace.

European medical cannabis is being built like pharma — not like dispensary retail. And Switzerland is the production hub. The cleanest case study is GrowMotion AG, a Zuchwil-based manufacturer that has spent five years engineering one of the most technologically advanced medical cannabis facilities on the continent.

Cannabis Marketing Playbooks are undergoing a fundamental shift following the latest federal rescheduling decision, forcing brands to rethink strategy, spend, and execution in 2026. Cannabis Just Got Schedule III. Most Marketing Playbooks Just Got Obsolete. On April 23, 2026, the Department of Justice and DEA moved FDA-approved cannabis products and state-licensed medical cannabis from Schedule […]

CBD is gaining popularity due to its potential health benefits and changing regulations around its sale and distribution.

Back in 2018, when Mike Mejer first noticed cannabis companies struggling to promote their brands and narratives, he decided to take flight and learn more.

Brand building inside a federal-versus-state regulatory split.